Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalayoglu

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Blood|February 27, 2026
Isatuximab, bortezomib, lenalidomide, dexamethasone for multiple myeloma: dynamics of MRD-negativity in the IMROZ studyRobert Z Orlowski, Meletios A Dimopoulos, Xavier Leleu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 3, 2020
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory MyelomaMeral Beksac, Yildiz Aydin, Hakan Goker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2013
Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantationEric Spierings, Yeung-Hyen Kim, Matthijs Hendriks, et al.
Transplantation|July 27, 1997
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study GroupL S Sher, C A Cosenza, J Michel, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trialTuan Vu, Hacer Durmus, Michael Rivner, et al.
The New England Journal of Medicine|June 4, 2024
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple MyelomaThierry Facon, Meletios-Athanasios Dimopoulos, Xavier P Leleu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 12, 2022
Criteria for Hyperinflammation Developing in COVID-19: Analysis of 2 Cohorts From Different Periods of the PandemicShirkhan Amikishiyev, M Guven Gunver, Murat Bektas, et al.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trialRenee R Fedak, Rachel N Ruggerie, Yufei Shan, et al.
Hematological Oncology|June 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective studyOlga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Blood|February 27, 2026
Isatuximab, bortezomib, lenalidomide, dexamethasone for multiple myeloma: dynamics of MRD-negativity in the IMROZ studyRobert Z Orlowski, Meletios A Dimopoulos, Xavier Leleu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 3, 2020
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory MyelomaMeral Beksac, Yildiz Aydin, Hakan Goker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2013
Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantationEric Spierings, Yeung-Hyen Kim, Matthijs Hendriks, et al.
Transplantation|July 27, 1997
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study GroupL S Sher, C A Cosenza, J Michel, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trialTuan Vu, Hacer Durmus, Michael Rivner, et al.
The New England Journal of Medicine|June 4, 2024
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple MyelomaThierry Facon, Meletios-Athanasios Dimopoulos, Xavier P Leleu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 12, 2022
Criteria for Hyperinflammation Developing in COVID-19: Analysis of 2 Cohorts From Different Periods of the PandemicShirkhan Amikishiyev, M Guven Gunver, Murat Bektas, et al.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trialRenee R Fedak, Rachel N Ruggerie, Yufei Shan, et al.
Hematological Oncology|June 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective studyOlga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan, et al.
Pageof 22